Big Data EEG Recording and Analysis platform

Información del proyecto

WhiteBox EEG

Identificador del acuerdo de subvención: 729367

DOI

10.3030/729367

Proyecto cerrado

Fecha de la firma de la CE 1 Junio 2016

Fecha de inicio 1 Julio 2016

Fecha de finalización 31 Diciembre 2016

Financiado con arreglo a

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Coste total

€ 71 429,00

Aportación de la UE

€ 50 000,00

Coordinado por

BLCKB, DRUZBA ZA APLIKATIVNO NEVROZNANOST
Slovenia

Objetivo

The main objective of our project is to develop and commercialise a world`s first scalable, multipurpose, high-throughput, Big Data EEG Platform that connects and controls large number of individual EEG amplifiers at the same location. With this innovative solution, we are meeting increasing demands of researchers, doctors and other EEG practitioners for more efficient EEG recording, that has become a bottleneck in modern neuroscience, and for larger samples in EEG reseach.
Thus with the increased recording capacity of 10+ subjects simultaneously, up to 10 times faster recording output and up to 40% in cost savings compared to the existing EEG recording solutions, our innovative solution will disrupt the market for EEG research & medical diagnostics, EEG equipment and recording platforms and applied neuroscience. Furthermore, the high-throughput capabilities and the scalability of the WhiteBox platform provide an answer to a lack of larger databases of standardised and consistent EEG recordings, that enable Big Data approaches and which are crucial for the clinical validation of biomarkers. Our disruptive innovation not only makes the existing EEG recording and analysis faster and cheaper but through its scalability also represents a big opportunity to bring the benefits of EEG brain-imaging technology to new areas of use ranging from medical & research field (such as EEG based predictive disease diagnostics, personalised medicine, big data EEG analysis) to the emerging field of applied neuroscience (such as NeuroEducation, Neuromarketing/Consumer Neuroscience, Neuro-HR and Change Management, User Centred Neurodesign and EEG performance optimization in Professional Sports).
The purpose of the Phase 1 is to outline the full scope of further development potential of our innovative solution, involving the technical and business viability issues, also regarding the analysis of associated risks and the exploitation of the project`s commercial potential to the fullest.

Ámbito científico (EuroSciVoc)

• ciencias naturales › ciencias biológicas › neurobiología
• ciencias naturales › informática y ciencias de la información › ciencia de datos › macrodatos
• ciencias médicas y de la salud › medicina básica › neurología

Programa(s)

• H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being PROGRAMA PRINCIPAL
  
• H2020-EU.3.1.4. - Active ageing and self-management of health
  
• H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)
  
• H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
  
• H2020-EU.3.1.6. - Health care provision and integrated care
  

Tema(s)

• SMEInst-06-2016-2017 - Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well
  

Régimen de financiación

SME-1 - SME instrument phase 1

Convocatoria de propuestas

H2020-SMEInst-2016-2017

Coordinador

BLCKB, DRUZBA ZA APLIKATIVNO NEVROZNANOST

• Aportación neta de la UEn: € 50 000,00
• Dirección: VOJKOVA CESTA 63 ; 1000 LJUBLJANA ; Eslovenia
• Pyme Sí:
  Región
  Slovenija › Zahodna Slovenija › Osrednjeslovenska
• Región: Slovenija › Zahodna Slovenija › Osrednjeslovenska
• Tipo de actividad: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Coste total: € 71 429,00